
NEW HORIZONS IN TOXICITY PREDICTION Sponsored by: LHASA Limited: Session Chairs: Professor
Robert Glen, Dr Alan
Wilson, Lexicon Genetics Incorporated Dr
David Hawkins, Lhasa Limited Board of Directors DAY ONE: 9:30 am Welcome and Opening
Remarks Session 1: Current Approaches for Toxicity Prediction
Current Status of Toxicity Prediction
What is currently available?
How are these tools being used by Regulators,
Industry & Academia ?
Unmet needs? 9:45 am Opening
Remarks Dr David Hawkins (Chair) 9:50 am Pharmaceutical
Regulatory Perspective [Abstract] 10:25 am In Silico Tools & Guidance developed by the European Chemicals Bureau [Abstract]
11:00 am Break 11:30 am Modelling and informatics support for safety an metabolism studies in early drug discovery projects [Abstract] Dr Scott Boyer, Astra Zeneca 12:05
am Recent Developments in Toxico-Cheminformatics: Supporting a New Paradigm for Predictive Toxicology [Abstract]
Dr Ann Richard, US
Environmental Protection Agency 12:40 pm Lunch Session 2: Strengths and Limitations of
Current Toxicity Prediction Systems
How do different approaches compare (QSAR, Knowledge-Based,
Neural Networks)
Pros and Cons of different systems
Toxicity databases and tool boxes 2:00 pm Opening Remarks Professor Robert Glen (Chair) 2:10 pm The Role of
Predictive Data Mining in Understanding Toxicity [Abstract] Professor Chihae Yang, Leadscope Inc. 2:45 pm Consensus QSAR Models [Abstract] Dr Mark Cronin, 3:20 pm Break 3:55 pm QSAR Approaches,
Models & Statistics Relating to Toxicity Prediction [Abstract] Professor Douglas Hawkins, 4:30 pm Knowledge-Based Approaches Dr Nigel Greene, Pfizer 5:05 pm Models and Databases
for Genetic/Carcinogenic Toxicity Aldo Benigni, National Institute of 5:40 pm- End - 7.30pm Symposium
Dinner: Peterhouse: College Campus DAY TWO: Session 3 Emerging Areas and Technologies in Toxicity Prediction
8:30 am Opening Remarks Dr Alan Wilson (Chair) 8:40 am Use of Biosimulation and Toxicogenomics to Predict the Efficacy of
Antiatherogenic Therapies, Cardiovascular Toxicity and Outcomes [Abstract] Dr Héctor De León, Entelos 9:15 am Emerging Areas in Toxicity Prediction: NIHS Perspective [Abstract] Dr Akihiko Hirose,
National Institute of Health Sciences, 9:50 am Coffee Break 10:20am Consumer Products
Industries Perspective [Abstract] Dr Cameron MacKay, Unilever - Safety & Environmental Assurance Centre 10:55 am Challenges In
Predicting Metabolism & Toxicity with Known & Abstract Targets [Abstract] Dr Fred Guengerich, Vanderbilt University 11:30 am Panel
Discussion: Future Needs and Challenges*
Identification of Gaps, Future Needs and Challenges
Increasing application of in silico modeling
Barriers to implementation 1:00 pm Closing Remarks
& End of Conference
Dr David Hawkins & Professor Robert
Glen (Chair)
Dr Edwin J. Matthews, Food & Drug
Administration
Dr

